足月新生儿出生后前两周血浆游离甲状腺素和促甲状腺素的年龄特异性参考区间
该研究旨在建立足月新生儿出生后3-7天和13-15天血浆游离甲状腺素(fT4)和促甲状腺素(TSH)的参考区间。采集120名健康新生儿的静脉血,使用免疫分析法测定fT4和TSH,计算95%参考区间。结果显示fT4参考区间下限在3-7天为20.5 pmol/L,13-15天为15.3 pmol/L,均明显高于成人参考区间下限。作者建议怀疑先天性甲状腺功能减退时,应使用已建立新生儿参考区间的检测方法,并考虑新生儿日龄。
要点
- 足月新生儿fT4的95%参考区间:3-7天为20.5-37.1 pmol/L,13-15天为15.3-26.5 pmol/L。
- 足月新生儿TSH的95%参考区间:3-7天为1.0-8.4 mU/L,13-15天为1.4-8.6 mU/L。
- fT4参考区间下限在3-7天为20.5 pmol/L、13-15天为15.3 pmol/L,明显高于该检测方法的成人参考区间下限。
核心结论
- 足月新生儿fT4参考区间下限在3-7天为20.5 pmol/L,13-15天为15.3 pmol/L,均明显高于该检测方法的成人参考区间下限。
- 怀疑先天性甲状腺功能减退时,作者推荐使用已建立新生儿参考区间的检测方法测定fT4和TSH,并考虑新生儿的日龄。
研究设计与样本
- 在荷兰,新生儿在出生后3-7天接受筛查;筛查结果提示中枢性先天性甲状腺功能减退时,儿科会诊平均在出生后第14天进行。
- 研究在t=1(3-7天)和t=2(13-15天)两个时间点从120名健康足月新生儿采集静脉血,其中94名在两个时间点均提供血样,52名仅在t=1或t=2提供血样。
- 共有146名参与者(49%为女性)至少有一次测量结果。
- fT4和TSH使用免疫分析法(Cobas;Roche Diagnostics)测定。
- 参考区间对正态分布数据使用95%置信区间计算,对非正态分布数据使用非参数百分位数法计算。
主要发现
- fT4的95%参考区间在3-7天为20.5-37.1 pmol/L,在13-15天为15.3-26.5 pmol/L。
- TSH的95%参考区间在3-7天为1.0-8.4 mU/L,在13-15天为1.4-8.6 mU/L。
- fT4参考区间下限在3-7天为20.5 pmol/L,在13-15天为15.3 pmol/L,均明显高于该检测方法的成人参考区间下限。
关键数值与推荐
- 中枢性先天性甲状腺功能减退的诊断基于fT4降低且TSH无明显升高。
- 甲状腺性先天性甲状腺功能减退的诊断基于TSH升高且fT4降低。
临床怎么用
- 怀疑先天性甲状腺功能减退时,作者推荐使用已建立新生儿参考区间的检测方法测定fT4和TSH,并考虑新生儿的日龄。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: Congenital hypothyroidism (CH) is a common and preventable cause of mental retardation, which is detected in many neonatal screening programs. Upon suspicion of CH, plasma free thyroxine (fT4) and thyrotropin (TSH) concentrations are measured. CH can be of thyroidal or central origin (CH-T and CH-C, respectively). While CH-T diagnosis is based on an elevated TSH with a low fT4, CH-C diagnosis is based on a low fT4 without a clearly elevated TSH. Currently, reliable neonatal reference intervals (RIs) for plasma fT4 and TSH are lacking. Age-specific RIs would greatly improve the diagnostic process for CH, especially for CH-C. Our aim was to establish neonatal RIs for plasma fT4 and TSH in term neonates at day 3-7 (t = 1) and day 13-15 (t = 2). The study was particularly designed to provide a reliable fT4 lower limit of the RI to facilitate the diagnosis of CH-C. In the Netherlands, neonates are screened at day 3-7 of life. After a screening result suggestive for CH-C, pediatric consultation takes place on average at day 14. Thus, the time points were chosen accordingly. Methods: Venous blood was collected from 120 healthy neonates at each time point (94 participants provided blood samples at two time points; 52 participants provided a sample at t = 1 or t = 2). fT4 and TSH were measured using an immunoassay (Cobas; Roche Diagnostics). RIs were calculated using the 95% confidence interval for normally distributed data and the nonparametric percentile method if data were not normally distributed. Results: From 146 participants (49% female), ≥1 measurement was available. Ninety-five percent RIs for fT4 were 20.5-37.1 pmol/L (day 3-7) and 15.3-26.5 pmol/L (day 13-15). Ninety-five percent RIs for TSH were 1.0-8.4 mU/L (day 3-7) and 1.4-8.6 mU/L (day 13-15). Conclusions: Our results indicate an fT4 lower limit of the RI of 20.5 pmol/L at day 3-7 and 15.3 pmol/L at day 13-15. These lower limits are considerably higher than this assay's lower limit of the adult RI for fT4. In case CH is suspected, we recommend measuring fT4 and TSH using an assay with an established neonatal RI, taking into account the child's age in days.
引用
- Naafs JC, Heinen CA, Zwaveling-Soonawala N, et al. Age-Specific Reference Intervals for Plasma Free Thyroxine and Thyrotropin in Term Neonates During the First Two Weeks of Life. Thyroid. 2020. PMID: 32126889. doi:10.1089/thy.2019.0779
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。